Expression of MicroRNA-24 in Aflatoxin B1 Exposed Patients with Hepatocellular Carcinoma and Cirrhosis | ||||
| Mansoura Journal of Forensic Medicine and Clinical Toxicology | ||||
| Article 6, Volume 26, Issue 2, July 2018, Page 67-82 PDF (543.97 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjfmct.2018.47006 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Afaf M Attia  1; Dina Elhammady2; Maha R Habeeb3; Neven F Abbas3; Maysaa E Zaki4
| ||||
| 1Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Mansoura University, Egypt. | ||||
| 2Tropical Medicine Department, Faculty of Medicine, Mansoura University, Egypt. | ||||
| 3Internal Medicine, Hepatology and Gastroenterology Department, Faculty of Medicine, Mansoura University, Egypt. | ||||
| 4Clinical Pathology Department, Faculty of Medicine, Mansoura University, Egypt. | ||||
| Abstract | ||||
| This study aimed to assess the role of micro-ribonucleic acid-24 (microRNA-24) expression in patients with cirrhosis and hepatocellular carcinoma (HCC) who have experienced high levels of aflatoxin B1 (AFB1) exposure. Fifty HCC and 24 hepatic cirrhosis patients, in addition to 20 healthy control subjects were included in this study. Aflatoxin B1 was measured by enzyme-linked immunosorbent assay (ELISA) and microRNA-24 was detected using real-time polymerase chain reaction (real-time PCR). Both aflatoxin B1 levels and microRNA-24 expression were found to be significantly increased in all patient groups in comparison to controls, more so in the HCC than cirrhotic group (p<0.0001). A highly significant correlation was detected between levels of AFB1 and amount of microRNA-24 expressed in both patient groups relative to their control counterparts (p<0.0001). Receiver Operating Characteristic (ROC) curve performed to evaluate the ability of microRNA-24 to differentiate between HCC and cirrhosis showed that it had sensitivity of 80% and specificity of 63% at cutoff 1.3, which was highly significant (p<0.0001). Increased aflatoxin B1 levels detected in patients with cirrhosis and HCC further support previous studies evaluating the level of exposure of the Egyptian population to this carcinogen and support the critical role of aflatoxin B1 in the appearance of HCC. In addition, microRNA-24 expression levels demonstrated in both cirrhosis and HCC might be valuable for use as a noninvasive diagnostic tool for diagnosis of HCC. | ||||
| Keywords | ||||
| Aflatoxin B1; Hepatocellular carcinoma; Cirrhosis; MicroRNA-24 | ||||
|
Statistics Article View: 119 PDF Download: 171 |
||||
